News

October 7, 2026

reverSASP was featured on TBS’s economics and business program, 「TBS CROSS DIG」.

reverSASP Therapeutics Co., Ltd. Featured on TBS CROSS DIG in a Special on Mitsui Fudosan’s Life Science Business

The program spotlighted the life science business of Mitsui Fudosan Co., Ltd., which positions itself as an “industrial developer,” exploring the frontiers of drug discovery and life sciences in Japan, including the value of communities that connect researchers and open innovation initiatives bringing together more than 1,000 participants. reverSASP was featured as a tenant company of MITSUI LINK-Lab, Mitsui Fudosan’s rental lab and office facilities. The segment showcased the company’s laboratory and research activities, along with interviews with team members, highlighting reverSASP’s mission to deliver new treatment options to people living with ALS, a disease with very limited therapeutic options.

Program Details
Program: TBS CROSS DIG
Release date: October 7, 2026
Watch (in Japanese): https://www.youtube.com/watch?v=Tw7NchOm_04
Announcement by MITSUI LINK-Lab (in Japanese): https://www.mitsui-linklab.jp/information/1883/